Rare diseases
Investigational molecules
Locations
Back to Spain3 294 clinical trials in Madrid, Spain across 24 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
SpainStudy on Napabucasin, Paclitaxel, and Gemcitabine for Patients with Metastatic Pancreatic Cancer After Chemotherapy Failure
SpainStudy on the Safety and Effects of BIIB122 for Patients with LRRK2-Associated Parkinson's Disease
SpainStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
SpainStudy of Sotatercept for People with Pulmonary Arterial Hypertension
SpainStudy on the Effects of 3 vs 6 Cycles of Platinum-based Chemotherapy and Avelumab in Patients with Advanced Urothelial Cancer
SpainStudy of single-dose oritavancin safety and tolerability in children with acute bacterial skin and skin structure infections
SpainStudy on Abemaciclib, Letrozole, and Fulvestrant for Patients with Advanced HR-positive/HER2-negative Breast Cancer
SpainStudy of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes
SpainStudy on the Safety and Effectiveness of Osimertinib and Datopotamab Deruxtecan for Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer
SpainStudy of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
SpainStudy of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments
SpainThe busiest research cities in the country
What the registry says about research in the country
Investigating novel treatments for cutaneous lupus erythematosus and immune thrombocytopenia, with studies evaluating new therapeutic approaches to manage these challenging conditions.
Research focuses on improving treatment outcomes and quality of life for patients with autoimmune disorders.
Clinical trials examining innovative therapies for Type 1 Diabetes in combination with weight management, targeting both glycemic control and obesity-related complications.
Studies aim to develop comprehensive treatment approaches for complex metabolic conditions.
Breakthrough research in multiple sclerosis and acute ischemic stroke, exploring new therapeutic options for both pediatric and adult populations.
Focus on developing targeted treatments to improve neurological outcomes and patient care.
Comprehensive vaccine studies targeting respiratory syncytial virus, influenza, and herpes zoster, with particular attention to vulnerable populations.
Research aims to enhance protection against common and serious infectious diseases.
Innovative studies in mantle cell lymphoma and bladder cancer, exploring combination therapies and targeted treatments to improve patient outcomes.
Focus on developing more effective and personalized cancer treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
